Director: Dr Jane Kaye
- Melham KA, Hawkins N, Kanellopoulou N, Kaye J, Gowans H, and Curren L (2013) Ownership of Biomedical Information in Biobanks In: Comparative Issues in the Governance of Research Biobanks, ed. by Pascuzzi, G and Izzo, U and Macilotti, M, Springer Verlag. (ISBN: 9783642331152).
- Borry Pascal, van Hellemondt Rachel E, Sprumont Dominique, Jales Camilla FD, Rial-Sebbag Emmanuelle, Spranger Tade M, Curren Liam, Kaye Jane, Nys Herman, and Howard Heidi (2012) Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet, 20(7):715-21.
- Budin-Ljøsne Isabelle, Harris Jennifer R, Kaye Jane, Knoppers Bartha M, Tassé Anne M, Bravo Elena, Cambon-Thomsen Anne, Eriksson Mikael, Kyvik Kirsten O, Litton Jan-Eric, Perola Markus, and Rial-Sebbag Emmanuelle (2012) ELSI challenges and strategies of national biobank infrastructures Norsk Epidemiologi, 21(2):155-160.
- Kaye Jane (2012) The Tension Between Data Sharing and the Protection of Privacy in Genomics Research Annu. Rev. Genomics Hum. Genet.
- Kaye Jane (2012) Embedding biobanks as tools for personalised medicine Norsk Epidemiologi, 21 (2):169-75.
|Contact address||Nuffield Dept of Population Health, Old Road Campus, Headington, Oxford, OX3 7LF|
|Department||Nuffield Department of Population Health|
|College||St Cross College|
Jane Kaye, D.Phil., L.L.B.
Dr. Jane Kaye is a Director of the Centre for Law, Health and Emerging Technologies at Oxford: HeLEX at the University of Oxford http://helex.medsci.ox.ac.uk/ The centre specialises in investigating the relationships between law, ethics, and practice in the area of emerging technologies in health. She obtained her degrees from the Australian National University (BA); University of Melbourne (LLB); and University of Oxford (DPhil). She was admitted to practice as a solicitor/barrister in 1997 and is a member of the University of Oxford’s Faculty of Law. She is also on a number of international expert committees and scientific advisory boards and was on the UK Ethics and Confidentiality Committee of NIGB. She is one of the leaders in the ELSI2.0 Initiative http://www.sciencemag.org/content/336/6082/673.summary and the Making Connections network on the governance of biobanks. She was the Rapporteur for the EC Expert Report, Biobanks for Europe - The Challenges for Governance June 2012 http://www.publichealth.ox.ac.uk/helex/biobanks_for_Europe.pdf and is on the editorial boards of Law, Innovation and Technology, the Journal of Law and Information Science and Life Sciences, Policy and Society.